Veriheal

APRIL 1, 2024

Cannabis is not legal in North Carolina for medicinal or recreational purposes yet, but one group has their own rules–the Eastern Band of Cherokee Indians (EBCI). aims to provide patients with safe and regulated access to medicinal cannabis products,” Qualla Enterprises wrote in their official press release.

Dispensary 106

Dispensary Chronic Pain Medicine History 106

Veriheal

FEBRUARY 6, 2024

These new proposals are designed to expand access to medical cannabis for NJ MMJ patients. The low number of patients is puzzling, considering that New Jersey’s list of qualifying conditions for medical cannabis is extensive. The public comment period is open from October 16 to December 15, 2023. An ounce runs about $455.”

Programs 67

Programs Access Dispensary Chronic Pain 67

Illinois News Joint

JULY 13, 2023

Governor JB Pritzker and the Illinois Department of Financial and Professional Regulation (IDFPR) announced today the results of the Social Equity Criteria Lottery (SECL) for 55 Conditional Adult Use Cannabis Dispensary Licenses. All winners now have the opportunity to be issued a conditional license.

Conditions 80

Conditions Dispensary Retail Access 80

Canna Law Blog

AUGUST 25, 2023

On August 9, 2023, we wrote about the temporary injunction ordered by Judge Kevin Bryant in New York Supreme Court, County of Albany which occurred on August 7, 2023. They are also constrained from conferring operational approval upon any more provisional or existing CAURD licenses, pending further order of the Court.

Programs 65

Programs State Laws Retail Dispensary 65

Veriheal

JANUARY 1, 2024

As debates heat up over recreational cannabis, all eyes turn to Ohio and its potential legalization. Ohio, often viewed as a bellwether state, now faces a defining question: Will it join the growing roster of states opting to launch legal recreational marijuana markets? Set rates too high, and legal sales become uncompetitive.

Recreational 112

Recreational Supply Chain Legislation Cannabis 112

Veriheal

DECEMBER 14, 2023

Debunking The Stigma It’s not difficult to find studies promoting fear-mongering over cannabis use, particularly ones working against the ongoing legalization and societal acceptance of medical marijuana. However, this claim needs further research to confirm. Fortunately, this type of study is becoming more common.

Chronic Pain 120

Chronic Pain Consumption Cannabis Marijuana 120

MMJ Recs

JANUARY 20, 2024

One such paradigm shift is the increasing acceptance and legalization of medical marijuana across various states. The state’s thoughtful approach seeks to ensure that those with genuine medical needs have access to this alternative treatment while maintaining a balance between patient care and preventing misuse.

Law 52

Law Marijuana Patients Chronic Pain 52

Canna Law Blog

MARCH 11, 2024

Washington state then provided a regulatory framework for how the legalization of recreational cannabis production, processing, and retail sales would be regulated under what would become the Washington State Liquor and Cannabis Board (“LCB”). The bill now waits for signatures and executive action to become law.

Chronic Pain 105

Chronic Pain Recreational Patients Medicine 105

Veriheal

MARCH 6, 2024

Department of Health and Human Services (HHS) recommended that the Drug Enforcement Agency (DEA) reshedule cannabis as a Schedule III substance in August of 2023. The HSS found strong scientific support regarding cannabis’ medically beneficial effects for conditions like anorexia , nausea, and chronic pain.

Research and Development 62

Research and Development DEA Chronic Pain Business 62

MMJ Recs

DECEMBER 13, 2023

Let’s take a look at the current state of medical marijuana dispensaries in Texas, examining the legal framework, patient access, and the potential impact on the healthcare landscape. Qualifying conditions include epilepsy, terminal cancer, multiple sclerosis, autism, and incurable neurodegenerative diseases.

Dispensary 52

Dispensary Patients Marijuana Epilepsy 52

Cannabis Law Report

MARCH 19, 2022

Publishing online and in print with open access options, Psychedelic Medicine will provide an authoritative, high-profile forum for groundbreaking original research papers, review articles, captivating front matter, debate, and commentary. Mary Ann Liebert Inc.,

Medicine 52

Medicine Decriminalization Pharmaceutical Topical 52

The Cannigma

JULY 5, 2022

The program was legalized in 2015 and patients with qualifying conditions can get a prescription for up to 20oz of low THC oil, capsules, patches, or lotion. In 2015, Georgia legalized possession of up 20 fl. oz of 5% or less THC oil for medical patients with qualifying conditions. Georgia’s medical cannabis program.

Law 96

Law Decriminalization Programs Patients 96

Illinois News Joint

FEBRUARY 29, 2024

Eligible applicants must be social equity Conditional and Adult Use Dispensing Organizations licensed by the Illinois Department of Finance and Professional Regulation (IDFPR). This round of funding is open to dispensaries that received licenses prior to the July 2023 dispensary license lottery.”

Programs 88

Programs Dispensary Access Cannabis 88

Cannabis Law Report

MAY 31, 2022

The short answer is: that current legal options (i.e. legal at the state level or the state and federal level) are limited. Stay tuned… Oregon plans to accept applications for Facilitators, Laboratories, Manufacturers and Service Centers starting January 2023. Federal Legal Status. Non-Commercial Operations.

Clinical Trials 52

Clinical Trials Legalization Therapy Decriminalization 52

Veriheal

MARCH 29, 2023

However, a 2023 study debunks many myths about the potential dangers of legalizing cannabis. This groundbreaking research, published in the Journal of the American Medical Association Psychiatry (JAMA), challenges previous claims that marijuana legalization increases psychosis and other mental health issues.

Legalization 57

Legalization Data Policy Cannabis 57

Veriheal

NOVEMBER 9, 2023

Traditional treatments for these conditions often involve medication, physical therapy, or more invasive interventions like surgery. A new 2023 study published in the journal Medical Cannabis and Cannabinoids revealed that using a THC/CBD spray can help significantly reduce chronic back and neck pain.

Treatment 109

Treatment Therapy Research and Development THC 109

MMJ Recs

OCTOBER 5, 2023

Maryland Medical Cannabis Laws Understanding the legal framework surrounding medical cannabis in Maryland is crucial for both patients and healthcare providers. These laws are designed to protect patients, provide access to treatment, and prevent abuse.

Dispensary 52

Dispensary Patients Treatment Conditions 52

Cannabis Law Report

FEBRUARY 28, 2022

The Board is made up of people who were appointed by the governor to create recommendations for the rules for the state’s legal psilocybin services, which begin in January 2023.

Research and Development 105

Research and Development Safety Policy Conditions 105

Cannabis Law Report

OCTOBER 4, 2021

A multitude of recent clinical trials shows the clear promise of psilocybin for this population suffering from these debilitating conditions. However, this drug is not presently legally available, as it is classified as a Schedule I drug, severely restricted and regulated by the federal Controlled Substances Act.

Therapy 52

Therapy Patients Law Clinical Trials 52

Veriheal

MARCH 31, 2022

New Jersey and New York — which legalized cannabis on Feb. 22, 2021, and March 31, 2021, respectively — have yet to officially get the ball rolling in terms of launching their legal markets. Kathy Hochul signed legislation establishing a conditional cultivation and processing recreational licensing structure. New York Cannabis.

Recreational 52

Recreational Cultivation Conditions Agriculture 52

Canna Law Blog

MAY 17, 2023

As many familiar with the current status and issues facing New York State cannabis and specifically the conditional adult use retail dispensary (“ CAURD ”) licenses know, there are a multitude of problems that CAURD Licensees are facing and some of them are fed up. What’s next for CAURD?

Retail 68

Retail Dispensary Conditions Cannabis 68

Veriheal

FEBRUARY 17, 2022

states that have legalized cannabis in some form, but advocates have continued to work hard on cannabis legalization and decriminalization proposals. . A bill to legalize and regulate adult-use cannabis in Wyoming managed to fly through a House committee in March of last year. Wyoming may not have joined the 37 U.S.

Decriminalization 98

Decriminalization Legislation Cultivation Cannabis 98

Veriheal

SEPTEMBER 2, 2022

As more patients have sought out legal medical cannabis patient status in the country, it is believed that the number of registered U.K. Individuals in the country with conditions such as Parkinson’s disease, depression, insomnia, ADHD, multiple sclerosis, anxiety, chronic pain, and epilepsy have embraced the option of medical cannabis.

Chronic Pain 57

Chronic Pain Patients Decriminalization Cannabis 57

Canna Law Blog

MARCH 17, 2023

Here’s what the “petitioner” is requesting from a legal perspective: a judicial declaration that the OCM’s creation of the CAURD program exceeded the OCM’s authority under New York’s constitution (i.e. Here comes more New York cannabis program litigation.

Retail 74

Retail Dispensary Programs Cannabis 74

Veriheal

JUNE 20, 2023

In a recent 2023 study , scientists have developed two promising drug candidates for treating these conditions, drawing inspiration from a traditional African psychedelic plant medicine called ibogaine. Always consult a physician before making any decision on the treatment of a medical condition.

Medicine 98

Medicine Research and Development Treatment Conditions 98

NORML

MAY 31, 2019

Members of the New Hampshire Senate voted to delay consideration of a House-passed legalization bill until later this year. Legislation is pending, Senate Bill 236, to allow qualifying patients with certain debilitating conditions to use and safely access medical cannabis. The bill now heads to the governor’s desk.

Legislation 111

Legislation Access Banking Hemp 111

PrestoDoctor

FEBRUARY 13, 2023

Louis Skyline – Gateway Arch Getting your Missouri medical marijuanas card in 2023 is still beneficial. Learn about how to become a medical marijuana patient so you can get access to medical cannabis in Missouri. Beginning May 3rd, 2023, dispensaries will be required to scan patient and caregiver cards at the time of purchase.

Marijuana 52

Marijuana Conditions Patients Cultivation 52

The Cannigma

AUGUST 9, 2023

Pediatric cannabis ingestions are on the rise Legalization has led to an increase in pediatric ingestions. Numerous studies have found an association between legalization and the number of pediatric ingestions of THC-containing products; both intentional and unintentional ingestions are on the rise. 2 3 Why is packaging so important?

Packaging 77

Packaging Edibles Wellness and Beauty Blood Pressure 77

Cannabis Law Report

MAY 30, 2019

Retail sales of medical and recreational cannabis in the United States are on pace to eclipse $12 billion by the end of 2019 – an increase of roughly 35% over 2018 – and could rise as high as $30 billion by 2023. The third-largest medical market – Arizona – is poised to pass adult-use legalization via a ballot initiative in 2020.

Recreational 40

Recreational Retail Programs Dispensary 40

Cannabis Law Report

JANUARY 27, 2022

If passed the bill will establish the “Task Force on Psilocybin Equity” that will research problems relating to access and equity in Oregon’s emerging psilocybin program. The task force will complete a study and provide policy recommendations that will serve as a basis for substantive policy reforms during the 2023 legislative session.

Research and Development 52

Research and Development Policy Access Legislation 52

Cannabis Law Report

SEPTEMBER 22, 2022

These bills, which touch on issues that run the gamut of the cannabis industry, are intended to “strengthen California’s cannabis laws, expand the legal cannabis market and redress the harms of cannabis prohibition.” SB 1186– Medicinal Cannabis Patients’ Right of Access Act. SB 1326 – Cannabis: Interstate Agreements.

Law 52

Law Events Packaging Pets 52

Veriheal

MARCH 1, 2022

The first legal psilocybin therapy program to take shape in America is slowly progressing in Oregon. If everything goes according to plan, psilocybin therapy could be available publicly in Oregon as soon as 2023. The 17-person Psilocybin Advisory Board appointed by Gov. What is Psilocybin?

Therapy 98

Therapy Programs Microdosing Medicine 98

Cannabis Law Report

APRIL 21, 2022

Publication of this process establishes “prior art,” contributing to MAPS’ patient access strategy by making intellectual property public . Promising clinical trial results have generated much interest in studying MDMA as a catalyst to therapy for PTSD and related conditions — and an increased demand for pharmaceutical-grade MDMA.

Clinical Trials 52

Clinical Trials Research and Development Therapy Media 52

NORML

MARCH 22, 2019

Similarly, activists in Arizona are attempting to qualify a 2020 legalization ballot initiative. Governor Andrew Cuomo (D) of New York announced that marijuana legalization language will no longer appear in his budget proposal. Click here to email your lawmakers in support of legalization. CA resident? CO resident? Connecticut.

Legislation 137

Legislation Hemp Patients Compliance 137

Cannabis Law Report

SEPTEMBER 16, 2022

This article reviews cannabis laws in effect in Southern states, cannabis laws that will go into effect in the future, and examines states that haven’t passed legislation legalizing cannabis. Businesses seeking to participate in Mississippi’s medical cannabis program need a variety of legal assistance. Code § 16-12-191.

Law 52

Law Programs Cultivation Dispensary 52

Cannabis Law Report

MARCH 3, 2022

In 2020, Oregon voters approved Measure 109, which legalized psilocybin services and tasked OHA with creating a program to regulate psilocybin services in supervised settings at licensed facilities. Who is interested in accessing psilocybin services and why? Access to psilocybin services appears attractive across the gender spectrum.

Programs 52

Programs Access Data Legislation 52

Illinois News Joint

MARCH 11, 2024

MCAB board members took preliminary votes to include two qualifying debilitating conditions for medical cannabis patients in Illinois. After public comment, board members voted anonymously via private messages for two new conditions to be added, endometrioses and FOD (Female Organismic Disorder).

Conditions 89

Conditions Advocacy Patients Programs 89